China Drug Approvals Up 26%, Mostly Due To Generics
This article was originally published in PharmAsia News
Executive Summary
China's State FDA increased drug approvals by more than 26% in 2010, with the boost largely due to an increase in generic drug approvals. The agency also cleared more clinical trials for drugs that treat diseases that have a large societal impact, according to SFDA's second annual report on the status of drug approvals